The Manila Times on MSN
New recombinant mpox strain detected in UK and India, WHO urges continued monitoring
The detection of a newly identified recombinant mpox virus containing genetic material from two known strains underscores the need for continued genomic surveillance, the UN World Health Organization ...
The launch of AlbuFree™ DX underscores Dyadic’s strategy to prioritize recombinant protein products that have clear commercial pathways and are supported by well-established end markets. Under the ...
Federal Circuit revives REGENXBIO’s suit against Sarepta, reversing a Delaware ruling that found asserted host-cell claims ...
Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...
After migrating from misogynist forums to social media feeds, terms like “looksmaxxing” and “mogged” are now impossible to ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) in a precedential decision on Friday reversed a district court’s grant of summary judgment that REGENEXBIO, Inc.’s patent claims were ...
New analyses of efficacy endpoints from the Phase 2 VIBRANT trial of verekitug in CRSwNP to be presented during the late-breaking poster ...
Estée Lauder's new Revitalizing Supreme+ Sculpting Serum features 10X Concentrated Hexapeptide-8 + NEW Hexapeptide-9.
Four years after the FDA issued its most heavy-handed form of a rejection to the prior company behind pegzilarginase, the U.S. regulator has now given the treatment a thumbs-up. | Four years after the ...
Estée Lauder's new Revitalizing Supreme+ Sculpting Serum features 10X Concentrated Hexapeptide-8 + NEW Hexapeptide-9.
Learn more about whether Celldex Therapeutics, Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results